These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
636 related articles for article (PubMed ID: 26469742)
21. Regio- and stereoselective synthesis of dispirooxindole-pyrrolocarbazole hybrids via 1,3-dipolar cycloaddition reactions: Cytotoxic activity and SAR studies. Murali K; Sparkes HA; Rajendra Prasad KJ Eur J Med Chem; 2018 Jan; 143():292-305. PubMed ID: 29197734 [TBL] [Abstract][Full Text] [Related]
22. Synthesis and Cytotoxic Evaluation of Pyran, Dihydropyridine and Thiophene Derivatives of 3-Acetylcoumarin. Mohareb RM; Megally Abdo NY Chem Pharm Bull (Tokyo); 2015; 63(9):678-87. PubMed ID: 26329861 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of newly synthesized 2-(thiophen-2-yl)-1H-indole derivatives as anticancer agents against HCT-116 cell proliferation via cell cycle arrest and down regulation of miR-25. Abdelazeem NM; Gouhar SA; Fahmy CA; Elshahid ZA; El-Hussieny M Sci Rep; 2024 Aug; 14(1):20045. PubMed ID: 39209915 [TBL] [Abstract][Full Text] [Related]
24. Synthesis and biological evaluation of novel pyrimidine-benzimidazol hybrids as potential anticancer agents. Shao KP; Zhang XY; Chen PJ; Xue DQ; He P; Ma LY; Zheng JX; Zhang QR; Liu HM Bioorg Med Chem Lett; 2014 Aug; 24(16):3877-81. PubMed ID: 25001482 [TBL] [Abstract][Full Text] [Related]
25. Design, combinatorial synthesis and biological evaluations of novel 3-amino-1'-((1-aryl-1H-1,2,3-triazol-5-yl)methyl)-2'-oxospiro[benzo[a] pyrano[2,3-c]phenazine-1,3'-indoline]-2-carbonitrile antitumor hybrid molecules. Lu Y; Wang L; Wang X; Xi T; Liao J; Wang Z; Jiang F Eur J Med Chem; 2017 Jul; 135():125-141. PubMed ID: 28441581 [TBL] [Abstract][Full Text] [Related]
26. Novel thiosemicarbazides induced apoptosis in human MCF-7 breast cancer cells via JNK signaling. Malki A; Elbayaa RY; Ashour HM; Loffredo CA; Youssef AM J Enzyme Inhib Med Chem; 2015; 30(5):786-95. PubMed ID: 25363687 [TBL] [Abstract][Full Text] [Related]
27. In-silico and in-vitro anti-cancer potential of a curcumin analogue (1E, 6E)-1, 7-di (1H-indol-3-yl) hepta-1, 6-diene-3, 5-dione. Sufi SA; Adigopula LN; Syed SB; Mukherjee V; Coumar MS; Rao HS; Rajagopalan R Biomed Pharmacother; 2017 Jan; 85():389-398. PubMed ID: 27889234 [TBL] [Abstract][Full Text] [Related]
28. Synthesis and evaluation of indole-containing 3,5-diarylisoxazoles as potential pro-apoptotic antitumour agents. Md Tohid SF; Ziedan NI; Stefanelli F; Fogli S; Westwell AD Eur J Med Chem; 2012 Oct; 56():263-70. PubMed ID: 22955095 [TBL] [Abstract][Full Text] [Related]
29. Discovery of coumarin-monastrol hybrid as potential antibreast tumor-specific agent. Sashidhara KV; Avula SR; Sharma K; Palnati GR; Bathula SR Eur J Med Chem; 2013 Feb; 60():120-7. PubMed ID: 23287057 [TBL] [Abstract][Full Text] [Related]
30. Synthesis of novel indole derivatives as promising DNA-binding agents and evaluation of antitumor and antitopoisomerase I activities. Lafayette EA; de Almeida SMV; Cavalcanti Santos RV; de Oliveira JF; Amorim CADC; da Silva RMF; Pitta MGDR; Pitta IDR; de Moura RO; de Carvalho Júnior LB; de Melo Rêgo MJB; de Lima MDCA Eur J Med Chem; 2017 Aug; 136():511-522. PubMed ID: 28531811 [TBL] [Abstract][Full Text] [Related]
31. In Vitro Antitumor Evaluation of Some Hybrid Molecules Containing Coumarin and Quinolinone Moieties. Rizzk YW; El-Deen IM; Mohammed FZ; Abdelhamid MS; Khedr AIM Anticancer Agents Med Chem; 2019; 19(16):2010-2018. PubMed ID: 31566140 [TBL] [Abstract][Full Text] [Related]
32. Design, synthesis and biological evaluation of novel 3-substituted 4-anilino-coumarin derivatives as antitumor agents. Luo G; Muyaba M; Lyu W; Tang Z; Zhao R; Xu Q; You Q; Xiang H Bioorg Med Chem Lett; 2017 Feb; 27(4):867-874. PubMed ID: 28110871 [TBL] [Abstract][Full Text] [Related]
33. Synthesis and biological evaluation of spiro[cyclopropane-1,3'-indolin]-2'-ones as potential anticancer agents. Reddy CN; Nayak VL; Mani GS; Kapure JS; Adiyala PR; Maurya RA; Kamal A Bioorg Med Chem Lett; 2015 Oct; 25(20):4580-6. PubMed ID: 26330077 [TBL] [Abstract][Full Text] [Related]
34. Identification and characterization of novel indole based small molecules as anticancer agents through SIRT1 inhibition. Panathur N; Dalimba U; Koushik PV; Alvala M; Yogeeswari P; Sriram D; Kumar V Eur J Med Chem; 2013 Nov; 69():125-38. PubMed ID: 24013412 [TBL] [Abstract][Full Text] [Related]
35. New zirconium (IV) complexes of coumarins with cytotoxic activity. Kostova I; Momekov G Eur J Med Chem; 2006 Jun; 41(6):717-26. PubMed ID: 16697491 [TBL] [Abstract][Full Text] [Related]
36. Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents. Duan YC; Ma YC; Zhang E; Shi XJ; Wang MM; Ye XW; Liu HM Eur J Med Chem; 2013 Apr; 62():11-9. PubMed ID: 23353743 [TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological evaluation of novel coumarin-pyrazoline hybrids endowed with phenylsulfonyl moiety as antitumor agents. Amin KM; Eissa AA; Abou-Seri SM; Awadallah FM; Hassan GS Eur J Med Chem; 2013 Feb; 60():187-98. PubMed ID: 23291120 [TBL] [Abstract][Full Text] [Related]
38. Synthesis and anticancer activities of some new coumarin derivatives including the triazole ring and their in silico molecular docking studies. Menteşe E; Güner A; Polatlı E; Emirik M; Bektaş H; Kahveci B Arch Pharm (Weinheim); 2021 Mar; 354(3):e2000284. PubMed ID: 33146895 [TBL] [Abstract][Full Text] [Related]
39. Triazole tethered isatin-coumarin based molecular hybrids as novel antitubulin agents: Design, synthesis, biological investigation and docking studies. Singh H; Singh JV; Gupta MK; Saxena AK; Sharma S; Nepali K; Bedi PMS Bioorg Med Chem Lett; 2017 Sep; 27(17):3974-3979. PubMed ID: 28797799 [TBL] [Abstract][Full Text] [Related]
40. Synthesis, antitumor activity evaluation, and DNA-binding study of coumarin-based agents. Amin KM; Taha AM; George RF; Mohamed NM; Elsenduny FF Arch Pharm (Weinheim); 2018 Jan; 351(1):. PubMed ID: 29148081 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]